Carrie Page
About Carrie Page
Carrie Page is a Clinical Trial Manager with extensive experience in the pharmaceutical and clinical research sectors. She has held positions at notable organizations including Novartis, Pfizer, and MeiraGTx, and has academic qualifications in Toxicology and Biochemistry.
Current Role at MeiraGTx
Carrie Page serves as a Clinical Trial Manager at MeiraGTx, a position she has held since 2018. In this role, she is responsible for overseeing clinical trials, ensuring compliance with regulatory requirements, and managing study timelines and budgets. Her experience in clinical trial management contributes to the advancement of gene therapies at MeiraGTx.
Previous Experience in Clinical Research
Prior to her current role, Carrie Page worked at Novartis Institutes for BioMedical Research (NIBR) as a Clinical Project Manager from 2017 to 2018. She also held the position of Study Manager at Pfizer from 2001 to 2006 and served as Clinical Research Unit Manager at Epsom & St Helier University NHS Trust from 1993 to 2001. Additionally, she worked as a Study Manager at i3 Research from 2007 to 2010.
Educational Background
Carrie Page holds a Master of Science (MSc) in Toxicology from the University of Birmingham. She also earned a Bachelor of Science (BSc) in Biochemistry from Royal Holloway, University of London. Her educational background provides a strong foundation for her work in clinical trials and research.
Early Education
Carrie Page completed her early education at West Norfolk and Kings Lynn High School for Girls. This foundational education set the stage for her subsequent studies in biochemistry and toxicology.